EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.23p on 18-02-2026 at 19:40:08 |
|---|---|
| Change | 0.03p 15% |
| Buy | 0.24p |
| Sell | 0.22p |
| Last Trade: | Buy 1,539,583.00 at 0.24p |
| Day's Volume: | 78,678,509 |
| Last Close: | 0.23p |
| Open: | 0.20p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.20p - 0.23p |
| 52wk Range: | 0.18p - 0.30p |
| Market Capitalisation: | £4.94m |
| VWAP: | 0.209251p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,539,583 | 0.24p | Ordinary |
16:24:19 - 18-Feb-26 |
| Buy* | 3,750 | 0.24p | Ordinary |
16:23:27 - 18-Feb-26 |
| Buy* | 100,000 | 0.24p | Ordinary |
16:08:05 - 18-Feb-26 |
| Sell* | 104,804 | 0.2235p | Ordinary |
16:06:17 - 18-Feb-26 |
| Buy* | 125,000 | 0.24p | Ordinary |
16:06:09 - 18-Feb-26 |
| Buy* | 209,178 | 0.2398p | Ordinary |
16:05:20 - 18-Feb-26 |
| Buy* | 1,000,000 | 0.2375p | Ordinary |
15:42:58 - 18-Feb-26 |
| Buy* | 1,000,000 | 0.23p | Ordinary |
15:42:40 - 18-Feb-26 |
| Buy* | 250,000 | 0.2299p | Ordinary |
15:41:58 - 18-Feb-26 |
| Buy* | 431,760 | 0.23p | Ordinary |
15:37:51 - 18-Feb-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am | RNS-R | World Mental Health Day & Q4 Conference Schedule |